Cleared Traditional

K030263 - IMMUNICON CELLTRACKS ANALYZER

K030263 is an FDA 510(k) clearance for IMMUNICON CELLTRACKS ANALYZER, manufactured by Immunicon Corp.. The device is a Class 2 Hematology device with product code GKZ cleared through the Traditional 510(k) pathway after a 301-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2003
Decision
301d
Days
Class 2
Risk

K030263 is an FDA 510(k) clearance for the IMMUNICON CELLTRACKS ANALYZER. Classified as Counter, Differential Cell (product code GKZ), Class II - Special Controls.

Submitted by Immunicon Corp. (Huntingdon Valley, US). The FDA issued a Cleared decision on November 24, 2003 after a review of 301 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 864.5220 - the FDA hematology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Hematology review framework, consistent with the majority of Class II 510(k) submissions.

View all Immunicon Corp. devices

FDA 510(k) Submission Details - K030263

510(k) Number K030263 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 27, 2003
Decision Date November 24, 2003
Days to Decision 301 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
188d slower than avg
Panel avg: 113d · This submission: 301d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GKZ Device Classification - Class 2, Special Controls

Product Code GKZ Counter, Differential Cell
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 864.5220
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Hematology devices follow this clearance model.

Regulatory Peers - GKZ Counter, Differential Cell

All 304
Devices cleared under the same product code (GKZ) and FDA review panel - the closest regulatory comparables to K030263.
BD FACS 7-COLOR SETUP BEADS
K040026 · Becton Dickinson Immunocytometry Systems · Sep 2004
BD FACSCANTO SYSTEM
K040725 · Becton Dickinson Immunocytometry Systems · Sep 2004
SYSMEX AUTOMATED HEMATOLOGY ANALYZER, XE-2100 SERIES (XE-2100, XE-2100L)
K040073 · Sysmex America, Inc. · Mar 2004
COULTER LH 750 HEMATOLOGY ANALYZER
K032342 · Beckman Coulter, Inc. · Sep 2003
IMMATURE GRANULOCYTE (IG) PARAMETER ON THE SYSMEX MODEL XE-2100 AUTOMATED HEMATOLOGY ANALYZER
K032039 · Sysmex America, Inc. · Sep 2003
ADVIA 60 HEMATOLOGY ANALYZER
K032524 · Bayer Healthcare, LLC · Sep 2003